Zhejiang Int'l Group Co.,Ltd. (SHE:000411)
12.25
+0.27 (2.25%)
Feb 3, 2026, 3:04 PM CST
Zhejiang Int'l Group Revenue
Zhejiang Int'l Group had revenue of 8.33B CNY in the quarter ending September 30, 2025, with 2.05% growth. This brings the company's revenue in the last twelve months to 33.54B, up 1.90% year-over-year. In the year 2024, Zhejiang Int'l Group had annual revenue of 33.35B with 4.05% growth.
Revenue (ttm)
33.54B
Revenue Growth
+1.90%
P/S Ratio
0.21
Revenue / Employee
10.92M
Employees
3,072
Market Cap
6.92B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 33.35B | 1.30B | 4.05% |
| Dec 31, 2023 | 32.05B | 1.43B | 4.68% |
| Jan 1, 2023 | 30.62B | 3.89B | 14.55% |
| Jan 1, 2022 | 26.73B | 1.72B | 6.89% |
| Dec 31, 2020 | 25.01B | 407.28M | 1.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nanjing Pharmaceutical Group Company | 53.89B |
| Yifan Pharmaceutical | 5.22B |
| Zhejiang Jolly Pharmaceutical Co.,LTD | 2.81B |
| GuangYuYuan Chinese Herbal Medicine | 1.39B |
| Shanghai InnoStar Bio-tech | 829.92M |
| Chongqing Lummy Pharmaceutical | 771.02M |
| Hangzhou Minsheng Healthcare | 744.06M |
| Hangzhou Bio-Sincerity Pharma-Tech | 590.33M |